SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Tiziana Life Sciences shares are trading higher after the company announced it has been granted a US Patent on methods and use of Anti-CD3 Monoclonal Antibodies for the treatment of Crohn's Disease.

Benzinga · 08/18/2020 10:45